Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the skin and plasma concentrations of
minocycline in subjects undergoing treatment of acne vulgaris with oral extended release
minocycline. Acne lesion counts and safety/tolerance of the treatment will also be evaluated.